Linked Life Data

19825993

Source:http://linkedlifedata.com/resource/pubmed/id/19825993

Statements in which the resource exists as a subject.
PredicateObject
rdf:type
lifeskim:mentions
pubmed:issue
10
pubmed:dateCreated
2009-10-27
pubmed:abstractText
In the present study, we identified a missense mutation (G199V) in KAT-18 cell line established from primary cultures of anaplastic thyroid cancer (ATC). Notably, knockdown of this mutant (mt) p53 reduced cell viability and exerted antitumor activity equivalent to high doses of several chemotherapeutic agents. We showed that p53 knockdown had an antitumor effect via the induction of apoptosis. We further examined the underlying mechanism by which mt p53 (G199V) gains antiapoptotic function in KAT-18 cells. Microarray analysis revealed that p53 knockdown modified the expression of numerous apoptosis-related genes. Importantly, p53 knockdown led to downregulation of signal transducer and activator of transcription-3 (STAT3) gene expression. We further observed that p53 knockdown induced the downregulation of STAT3 protein. We also observed that a STAT3 inhibitor augmented the reduction of cell viability induced by p53 knockdown, whereas interleukin-6 treatment alleviated this effect. In addition, overexpression of STAT3 protected ATC cells against cell death induced by p53 knockdown. Taken together, these data show that mt p53 (G199V) gains antiapoptotic function mediated by STAT3 in ATC cells. Inhibition of the function of mt p53 (G199V) could be a novel and useful therapeutic strategy for decreasing the extent and severity of toxicity due to chemotherapeutic agents.
pubmed:language
eng
pubmed:journal
pubmed:citationSubset
IM
pubmed:chemical
pubmed:status
MEDLINE
pubmed:month
Oct
pubmed:issn
1557-3125
pubmed:author
pubmed:issnType
Electronic
pubmed:volume
7
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
1645-54
pubmed:meshHeading
pubmed-meshheading:19825993-Apoptosis, pubmed-meshheading:19825993-Carcinoma, pubmed-meshheading:19825993-Cell Line, Tumor, pubmed-meshheading:19825993-Cell Survival, pubmed-meshheading:19825993-Cell Transformation, Neoplastic, pubmed-meshheading:19825993-Dose-Response Relationship, Drug, pubmed-meshheading:19825993-Down-Regulation, pubmed-meshheading:19825993-Drug Resistance, Neoplasm, pubmed-meshheading:19825993-Enzyme Inhibitors, pubmed-meshheading:19825993-Gene Expression Regulation, Neoplastic, pubmed-meshheading:19825993-Humans, pubmed-meshheading:19825993-Interleukin-6, pubmed-meshheading:19825993-Mutation, Missense, pubmed-meshheading:19825993-RNA Interference, pubmed-meshheading:19825993-STAT3 Transcription Factor, pubmed-meshheading:19825993-Thyroid Neoplasms, pubmed-meshheading:19825993-Tumor Suppressor Protein p53
pubmed:year
2009
pubmed:articleTitle
Mutant p53 (G199V) gains antiapoptotic function through signal transducer and activator of transcription 3 in anaplastic thyroid cancer cells.
pubmed:affiliation
Department of Anatomy and Cell Biology, Dong-A University College of Medicine and Medical Science Research Center, Busan, South Korea.
pubmed:publicationType
Journal Article, Research Support, Non-U.S. Gov't